- Home
- DTST vs PYPD Comparison
DTST vs PYPD Comparison
Compare DTST & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- PYPD
- Stock Information
- Founded
- DTST 2001
- PYPD 2008
- Country
- DTST United States
- PYPD Israel
- Employees
- DTST N/A
- PYPD N/A
- Industry
- DTST EDP Services
- PYPD Medical/Dental Instruments
- Sector
- DTST Technology
- PYPD Health Care
- Exchange
- DTST Nasdaq
- PYPD Nasdaq
- Market Cap
- DTST 32.7M
- PYPD 30.1M
- IPO Year
- DTST N/A
- PYPD 2020
- Fundamental
- Price
- DTST $3.75
- PYPD $2.99
- Analyst Decision
- DTST
- PYPD Strong Buy
- Analyst Count
- DTST 0
- PYPD 2
- Target Price
- DTST N/A
- PYPD $10.50
- AVG Volume (30 Days)
- DTST 39.5K
- PYPD 18.1K
- Earning Date
- DTST 03-27-2025
- PYPD 02-12-2025
- Dividend Yield
- DTST N/A
- PYPD N/A
- EPS Growth
- DTST N/A
- PYPD N/A
- EPS
- DTST 0.02
- PYPD N/A
- Revenue
- DTST $25,143,911.00
- PYPD N/A
- Revenue This Year
- DTST $2.57
- PYPD N/A
- Revenue Next Year
- DTST $11.16
- PYPD N/A
- P/E Ratio
- DTST $186.28
- PYPD N/A
- Revenue Growth
- DTST 1.64
- PYPD N/A
- 52 Week Low
- DTST $3.24
- PYPD $2.37
- 52 Week High
- DTST $8.00
- PYPD $6.58
- Technical
- Relative Strength Index (RSI)
- DTST 34.10
- PYPD 49.42
- Support Level
- DTST $3.93
- PYPD $2.89
- Resistance Level
- DTST $4.27
- PYPD $3.27
- Average True Range (ATR)
- DTST 0.20
- PYPD 0.28
- MACD
- DTST -0.05
- PYPD 0.00
- Stochastic Oscillator
- DTST 0.00
- PYPD 45.89
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; Flagship Solutions, LLC and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.